Allspring Global Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$92.6M	Buy	281,793 +3,136	+1%	+$1.07M	0.16%	155
2025 Q4	$112M	Sell	278,657 -32,147	-10%	-$14.2M	0.18%	139
2025 Q3	$143M	Sell	310,804 -1,412	-0.5%	-$575K	0.23%	114
2025 Q2	$101M	Buy	312,216 +41,292	+15%	+$11.4M	0.17%	147
2025 Q1	$69.3M	Buy	+270,924	New	+$69.6M	0.12%	208
2024 Q4	–	Sell	-420	Closed	-$116K	–	1773
2024 Q3	$116K	Buy	420 +161	+62%	+$41.9K	﹤0.01%	1763
2024 Q2	$62.9K	Buy	259 +91	+54%	+$14.4K	﹤0.01%	1932
2024 Q1	$25.1K	Buy	168 +143	+572%	+$23.9K	﹤0.01%	2064
2023 Q4	$4.79K	Sell	25 -77,988	-100%	-$13.3M	﹤0.01%	2059
2023 Q3	$13.8M	Buy	78,013 +50,124	+180%	+$9.56M	0.02%	648
2023 Q2	$5.3M	Sell	27,889 -6,492	-19%	-$1.29M	0.01%	978
2023 Q1	$6.89M	Sell	34,381 -2,887	-8%	-$607K	0.01%	903
2022 Q4	$8.86M	Sell	37,268 -246	-0.7%	-$52.5K	0.02%	812
2022 Q3	$7.51M	Sell	37,514 -1,603	-4%	-$306K	0.01%	865
2022 Q2	$5.7M	Sell	39,117 -851	-2%	-$121K	0.01%	952
2022 Q1	$6.53M	Buy	39,968 +14,121	+55%	+$2.15M	0.01%	1036
2021 Q4	$4.38M	Buy	+25,847	New	+$4.8M	﹤0.01%	1225